[HTML][HTML] Alteration in the function and expression of SLC and ABC transporters in the neurovascular unit in Alzheimer's disease and the clinical significance

Y Jia, N Wang, Y Zhang, D Xue, H Lou, X Liu - Aging and disease, 2020 - ncbi.nlm.nih.gov
The neurovascular unit (NVU) plays an important role in maintaining the function of the
central nervous system (CNS). Emerging evidence has indicated that the NVU changes …

Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites

Y Zheng, X Zhang, R Zhang… - International …, 2023 - spandidos-publications.com
The intricate nature of Alzheimer's disease (AD) pathogenesis poses a persistent obstacle to
drug development. In recent times, neuroinflammation has emerged as a crucial pathogenic …

DL0410 Alleviates Memory Impairment in D‐Galactose‐Induced Aging Rats by Suppressing Neuroinflammation via the TLR4/MyD88/NF‐κB Pathway

B Zhang, W Lian, J Zhao, Z Wang… - … Medicine and Cellular …, 2021 - Wiley Online Library
Oxidative stress and neuroinflammation have been demonstrated to be linked with
Alzheimer's disease (AD). In this study, we examined the protective effects of DL0410 in …

Circulating extracellular vesicles in the aging process: impact of aerobic exercise

K Bertoldi, LR Cechinel, B Schallenberger… - Molecular and cellular …, 2018 - Springer
Our aim was to investigate transitory and delayed exercise effects on serum extracellular
vesicles (EVs) in aging process. Male Wistar rats of 3-, 21-, and 26-month old were allocated …

DL0410 attenuates oxidative stress and neuroinflammation via BDNF/TrkB/ERK/CREB and Nrf2/HO-1 activation

B Zhang, J Zhao, Z Wang, L Xu, A Liu, G Du - International …, 2020 - Elsevier
Oxidative stress and neuroinflammation have been deeply associated with Alzheimer's
disease. DL0410 is a novel acetylcholinesterase inhibitor with potential anti-oxidative effects …

DL0410 ameliorates cognitive disorder in SAMP8 mice by promoting mitochondrial dynamics and the NMDAR-CREB-BDNF pathway

W Lian, W Zhou, B Zhang, H Jia, L Xu, A Liu… - Acta Pharmacologica …, 2021 - nature.com
Alzheimer's disease (AD) is a worldwide problem and there are no effective drugs for AD
treatment. Previous studies show that DL0410 is a multi-target, anti-AD agent. In this study …

The mechanisms of Bushen-Yizhi formula as a therapeutic agent against Alzheimer's disease

H Cai, Y Luo, X Yan, P Ding, Y Huang, S Fang… - Scientific Reports, 2018 - nature.com
Bushen-Yizhi prescription (BSYZ) has been an effective traditional Chinese medicine (TCM)
prescription in treating Alzheimer's disease (AD) for hundreds of years. However, the …

Quercitrin improved cognitive impairment through inhibiting inflammation induced by microglia in Alzheimer's disease mice

L Wang, J Sun, Z Miao, X Jiang, Y Zheng, G Yang - Neuroreport, 2022 - journals.lww.com
Objective Diets rich in quercitrin show a neuroprotective effect, but the mechanism is not
very clear at present. The objective of this study is to explore the effect and mechanism of …

Protective effect of walnut on d‐galactose‐induced aging mouse model

J Liu, D Chen, Z Wang, C Chen, D Ning… - Food science & …, 2019 - Wiley Online Library
Objective (s) Accumulating evidence has suggested that oxidative stress and apoptosis are
involved in the aging process. d‐galactose (gal) has been reported to cause symptoms of …

[HTML][HTML] Micheliolide attenuates neuroinflammation to improve cognitive impairment of Alzheimer's disease by inhibiting NF-κB and PI3K/Akt signaling pathways

G Yang, Y Hu, X Qin, J Sun, Z Miao, L Wang, Z Ke… - Heliyon, 2023 - cell.com
Inflammatory reaction in the brain activates glial cells, and over-activated glial cells secrete
inflammatory mediators, which aggravates the inflammatory response in the brain and …